Part of Athagoras
                                                                                                                                                                                       

⚠️ The EUDAMED deadline is approaching.

From 28 May 2026, EUDAMED registration becomes mandatory in the EU for new devices before they are placed on the market.

For legacy devices that continue to be placed on the EU market after this date, manufacturers benefit from an additional transition period, with registration to be completed by 28 November 2026.

For many manufacturers, the real challenge is understanding how to prepare in time — from UDI and device data readiness to actor registration, certificates, and internal process alignment.

At confinis, our regulatory experts support medical device manufacturers through the EUDAMED process. We provide flexible, 360° regulatory advisory for medtech innovators navigating MDR and IVDR requirements.

📌 While you focus on innovation, we take care of the regulatory path!

confinis advises global product teams on EU and US pathway strategy, designation, and integrated evidence planning. Get in touch!

would you like to speak to us over the phone? just contact us and we’ll be in touch shortly